RARE

NASD Ultragenyx Pharmaceutical, Inc.
Oct 9, 2026 · 9:10 AM ET LAST TRADE Market Closed

$15.33 ↑ +0.04 (+0.26%) Trading Up from the previous close of $15.29

YTD change
-33.35%
vs 20-day SMA
+5.31%
vs 200-day SMA
-35.35%

Price ranges

Previous day
$14.43 $15.52
open $14.79 close $15.29
+$0.50 (+3.38%)
Today
$0.00 $0.00
$15.33
Past week
$14.08 $15.52
from $14.75 now $15.33
+$0.58 (+3.93%)
Past month
$12.73 $16.12
from $14.40 now $15.33
+$0.93 (+6.46%)
This year
$12.73 $36.57
from $23.00 now $15.33
-$7.67 (-33.35%)

Price & Performance

-8.62 (-36.05%) / 6M

$11.04$19.93$28.82$37.71Apr 9Jul 10Oct 8

Signals & Sentiment

Momentum, market sentiment, and recent alerts

Neutral
  • The stock is 91.5% away from all-time highs of $179.65
  • RARE is down 33% since the beginning of the year
  • RARE is down 52% over the past 12 months
  • RARE is up 6% over the past 1 month
  • 18% of all RARE investors are betting against RARE

RARE reads neutral: price sits above one of the two key moving averages, the 12-month move is -51.7%.

Financial Strength

Earnings, valuation, and balance sheet

Earnings

Profitable No
EPS $-0.9
Earnings momentum +3.0% Quarterly EPS growth
Quarterly change +3.0%

Valuation

P/E ratio N/A
Enterprise value $2.5B
Beta 1.45

Balance sheet & scale

IncomeN/A
Revenue$717.2M
Cash$301.0M
Debt$1.2M
Income / Debt N/A

Company & Peers

Company profile and competitor comparison

Company profile

ExchangeNASD
Sector Manufacturing
Sub Sector Chemical Manufacturing
Market cap $1.5B

Ultragenyx Pharmaceutical, Inc. is a biopharmaceutical company, which engages in the identification, acquisition, development, and commercialization of novel products for the treatment of genetic diseases. Its products include Crysvita, Mepsevii, Dojolvi, and Evkeeza. The company was founded by Emil D. Kakkis in April 2010 and is headquartered in Novato, CA.

Competitor comparison

TickerCompany PriceChange
LLY Eli Lilly and Company $1,169.60 -1.61%
JNJ Johnson & Johnson $256.48 -0.76%
ABBV AbbVie, Inc. $272.42 +0.39%
MRK Merck & Co., Inc. $142.38 -0.29%
RHHBY Roche Holding Ltd Sponsored ADR $53.37 -1.29%

You looked up one stock
Trade Ideas watches them all

Real-time scanning and AI-generated signals across the entire market.

See plans TI Pro Download

Prices and alerts are delayed by at least 20 minutes. Chart history reflects daily closing prices. Information is provided for research purposes only and is not investment advice.